Company · Ownership research

Noble Corp plc NE

CIK 0001895262

Form 4 transactions dated Nov 1, 2023 to Nov 9, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

This page lists 30 of 116 rows; the complete set is available through the API.

Insider filings on file run through Sep 8, 2026.

Insider purchases & sales

Purchased: $122.88M
Sold: $30.05M

Nov 1, 2023 – Sep 8, 2026
Available records · partial months are marked ·

202510 of 11 preview events

Date	Insider	Activity	Trade value (USD)	% of prior holding
Sep 8, 2025	Denton Blake SVP, Marketing & Contracts	Sale	$885.33K 29,729 shares sold	26.33% sold Direct holding	▾
Sep 5, 2025	Kawaja Joey M SVP, Operations	Sale	$1.00M 35,000 shares sold	30.85% sold Direct holding	▾
Apr 1, 2025	Howard Jennie SVP, Gen. Counsel & Corp. Sec.	Sale	$19.52K 808 shares sold	8.61% sold Direct holding	▾
Mar 11, 2025	Hirshberg Al J. Director	Purchase	$115.00K 5,000 shares bought	20.72% added Direct holding	▾
Mar 11, 2025	Hirshberg Al J. Director	Purchase	$115.00K 5,000 shares bought	New holding Trust holding	▾
Feb 20, 2025	SLEDGE CHARLES M Director	Purchase	$250.25K 8,992 shares bought	30.62% added Direct holding	▾
Feb 20, 2025	Barker Richard B. EVP and CFO	Purchase	$223.52K 8,000 shares bought	2.75% added Direct holding	▾
Feb 20, 2025	Eifler Robert W. President & CEO · Director	Purchase	$350.02K 12,568 shares bought	1.03% added Direct holding	▾
Feb 3, 2025	Kawaja Joey M SVP, Operations	Sale	$45.16K 1,435 shares sold	1.25% sold Direct holding	▾
Jan 30, 2025	Barker Richard B. EVP and CFO	Sale	$739.14K 22,813 shares sold	7.51% sold Direct holding	▾

Showing 11 / 11 record groups in 2025. The complete set is available through the API.

Noble Corp plc · NE

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 11 of 11 purchase / sale groups and 30 of 116 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_insider_transactions
{"action":"list","ticker":"NE","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.